Life Science Instrumentation and Research Tools Driving Transformational Growth through Automation—Global, 2023–2029

Life Science Instrumentation and Research Tools Driving Transformational Growth through Automation—Global, 2023–2029

A Steady Increase in Laboratory Budgets in Academia is Driving Innovation

This study analyzes the life science instrumentation and research tools industry, covering the chemicals, consumables, instruments, reagents, suppliers, and IT solutions used in research laboratories. The global market for life science instrumentation and research tools is projected to experience steady growth from 2023 to 2029, achieving significant revenue milestones, driven largely by laboratory automation and software solutions. As life science research becomes more expensive and budgets more constrained, traditional sales approaches to instruments and equipment are proving inefficient. There is an urgent need for new business models that can provide access to novel technologies without necessitating the purchase of all the equipment. There is also a greater demand for integrated instruments, software, and service solutions for workflow optimization, driven by the emergence of novel and advanced technologies like advanced microscopy, gene editing, and next-generation sequencing (NGS).

This study examines the factors driving and restraining the growth of the life science instrumentation and research tools industry. Application areas include academic institutes and governmental uses, clinical diagnostics, pharmaceuticals, and biotechnology. This research offers case studies from North America, Europe, Asia-Pacific (APAC), Latin America, and the Middle East, Africa, and South Asia (MEASA). It also identifies the core growth opportunities presented by the industry by evaluating industry segments, the regulatory environment, and emerging business models, as well as market revenue and forecasts.